Publications

March 20, 2025 - International Conference on Antiviral Research (ICAR 2025)

Tivoxavir marboxil, an Influenza Inhibitor Targeting Cap-dependent Endonuclease: Results from a Phase I Trial Demonstrating Safety, Tolerability and Pharmacokinetics and Demonstrating Protection Against H5N1 Bird Flu in a Rodent Challenge Model

Please click here to be notified of all upcoming news and publications.